As of 2025-06-15, the Fair Value of Pieris Pharmaceuticals Inc (PIRS) is -9.59 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 13.60 USD, the upside of Pieris Pharmaceuticals Inc is -170.49%.
With the market price of 13.60 USD and our fair value calculation, Pieris Pharmaceuticals Inc (PIRS) is not a good investment. Investing in PIRS stocks now will result in a potential loss of 170.49%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -25.47 | -37.23 | -45.74 | -33.28 | -24.54 | -33.25 |
| YoY growth | 4.80% | -46.18% | -22.85% | 27.24% | 26.25% | -2.15% |
| Market Cap (mil) | 113.15 |
| P/E | |
| Forward P/E |
| EPS | -1.92 |
| Avg earnings growth rate | -2.15% |
| TTM earnings | -15.95 |